Five pharma firms collaborate for Covid oral drug trial
Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2
Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2
